Latest AI and machine learning research in oncology/hematology for healthcare professionals.
Chemodynamic therapy (CDT), which harnesses endogenous chemical energy within the tumor microenviron...
BACKGROUND: Cervical cancer is the fourth most common malignant tumor in women globally, with tobacc...
BACKGROUND: Dihydroorotate dehydrogenase (DHODH), an important enzyme in de-novo pyrimidine synthesi...
BACKGROUND: Older survivors of cancer face heightened risk of depression and anxiety related to canc...
PURPOSE: This study addresses critical gaps in automated lymphoma segmentation from PET/CT imaging, ...
BACKGROUND: Some researchers have explored the application of radiomics-based machine learning to de...
Cell-free DNA can be used for early cancer detection, minimal residual disease monitoring, and post-...
Metabolic biomarkers offer promising opportunities for lung cancer risk assessment and early detecti...
BRAF mutations are key oncogenic alterations across multiple malignancies, including melanoma, thyro...
Clinical oncology increasingly depends on molecular information, but many assays still detach analyt...
Osimertinib is a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor ...
Ultrasound has emerged as a versatile, non-invasive imaging technique in dermatology, offering real-...
Breast fibrosis (BF) after radiotherapy remains one of the most dreaded late toxicities in breast ca...
Malignant intestinal obstruction (MIO) is a severe complication of advanced cancer. Traditional stat...
Large language models (LLMs) like GPT have been proposed to support complex clinical decision-making...
Acute myeloid leukemia (AML) is a genetically and phenotypically heterogeneous hematological maligna...
Skip metastasis-defined as lateral lymph node metastasis(N1b) in the absence of central lymph node i...
Cancer drug resistance, driven by complex genetic mutations, epigenetic plasticity, and tumor microe...
Glioblastoma multiforme (GBM) is the most aggressive primary brain tumor in adults, with a median su...
Glioblastoma (GBM) is the most common and aggressive primary malignant brain tumor, characterized by...
Accurate molecular profiling from routine histopathology slides could transform clinical oncology. A...